Evaluation of motor recovery after stroke with indication for early rehabilitation.-Definition of prognostic factors and medical economic analysis.

Recruiting

Conditions: Cerebral infarction
I61
Intracerebral haemorrhage
I63
I64
Stroke, not specified as haemorrhage or infarction

Registration Number: DRKS00032100

Lead Sponsor: Klinik und Poliklinik für Neurologie, Uniklinik Köln

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 150

Inclusion Criteria

First ever Stroke (ICD: I61, I63, I64)
NIHSS acute >0 Points
Frührehe-Barthel-Index <30 points
Stroke onset 72 hours

Exclusion Criteria

Subarachnoid hemorrhage (SAB), traumatic brain injury, hemorrhage into preformed cavities, other brain pathology significantly affecting prognosis (e.g., tumor, metastases).
Other disease determining the prognosis (e.g., acute myocardial infarction, endocarditis, cancer, multiple sclerosis)
Barthel index 30 points or above (thus not suitable for phase B)
Planned surgical procedures in the next 3 months
Cognitive impairment that makes informed consent impossible
Death as a result of the disease up to T1
Lack of patient compliance
Lack of informed consent from patient or relatives

Study & Design

Study Type: observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint of the study is the motor function recovery after stroke, within the first 6 months of rehabilitation. For this purpose, a physical examination will be performed at three time points (T0, T1, T2). This includes, the Fugl-Meyer Assessment and the following scales: Barthel-Index, NIHSS, mRS, FIM and FAM. <br>T0 represents the time of study inclusion, here the patient is examined after consent on the stroke unit within the first 48 hours after stroke. <br>T1 defines the time at the end of the early rehabilitation in the Department of Neurology, University Hospital Cologne. <br>T2: represents the follow-up date after 6 months in the Polyclinic for Neurology, University Hospital Cologne

Secondary Outcome Measures